» Articles » PMID: 27777904

Genetics of Prader-Willi Syndrome and Prader-Will-Like Syndrome

Overview
Specialty Pediatrics
Date 2016 Oct 26
PMID 27777904
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

The Prader-Willi syndrome (PWS) is a human imprinting disorder resulting from genomic alterations that inactivate imprinted, paternally expressed genes in human chromosome region 15q11-q13. This genetic condition appears to be a contiguous gene syndrome caused by the loss of at least 2 of a number of genes expressed exclusively from the paternal allele, including , , , and several , but it is not yet well known which specific genes in this region are associated with this syndrome. Prader-Will-Like syndrome (PWLS) share features of the PWS phenotype and the gene functions disrupted in PWLS are likely to lie in genetic pathways that are important for the development of PWS phenotype. However, the genetic basis of these rare disorders differs and the absence of a correct diagnosis may worsen the prognosis of these individuals due to the endocrine-metabolic malfunctioning associated with the PWS. Therefore, clinicians face a challenge in determining when to request the specific molecular test used to identify patients with classical PWS because the signs and symptoms of PWS are common to other syndromes such as PWLS. This review aims to provide an overview of current knowledge relating to the genetics of PWS and PWLS, with an emphasis on identification of patients that may benefit from further investigation and genetic screening.

Citing Articles

Sex dimorphic associations of Prader-Willi imprinted gene expressions in umbilical cord with prenatal and postnatal growth in healthy infants.

Mas-Pares B, Carreras-Badosa G, Gomez-Vilarrubla A, De Arriba-Munoz A, Lafalla-Bernard O, Prats-Puig A World J Pediatr. 2025; 21(1):100-112.

PMID: 39838229 PMC: 11813995. DOI: 10.1007/s12519-024-00865-4.


Endocrine features of Prader-Willi syndrome: a narrative review focusing on genotype-phenotype correlation.

Madeo S, Zagaroli L, Vandelli S, Calcaterra V, Crino A, de Sanctis L Front Endocrinol (Lausanne). 2024; 15:1382583.

PMID: 38737552 PMC: 11082343. DOI: 10.3389/fendo.2024.1382583.


UBE3A: The Role in Autism Spectrum Disorders (ASDs) and a Potential Candidate for Biomarker Studies and Designing Therapeutic Strategies.

Roy B, Amemasor E, Hussain S, Castro K Diseases. 2024; 12(1).

PMID: 38248358 PMC: 10814747. DOI: 10.3390/diseases12010007.


A 14-year-old male patient with diagnosis of Prader-Willi syndrome in Ethiopia: a case report.

Belay K, Ayalew B, Amogne M, Alemneh T, Geletew T J Med Case Rep. 2023; 17(1):530.

PMID: 38143282 PMC: 10749498. DOI: 10.1186/s13256-023-04282-5.


Neurologic orphan diseases: Emerging innovations and role for genetic treatments.

Kioutchoukova I, Foster D, Thakkar R, Foreman M, Burgess B, Toms R World J Exp Med. 2023; 13(4):59-74.

PMID: 37767543 PMC: 10520757. DOI: 10.5493/wjem.v13.i4.59.


References
1.
Lee H, Hwang J . Central precocious puberty in a girl with Prader-Willi syndrome. J Pediatr Endocrinol Metab. 2013; 26(11-12):1201-4. DOI: 10.1515/jpem-2013-0040. View

2.
Keverne E . Genomic imprinting in the brain. Curr Opin Neurobiol. 1997; 7(4):463-8. DOI: 10.1016/s0959-4388(97)80023-2. View

3.
Milner K, Craig E, Thompson R, Veltman M, Thomas N, Roberts S . Prader-Willi syndrome: intellectual abilities and behavioural features by genetic subtype. J Child Psychol Psychiatry. 2005; 46(10):1089-96. DOI: 10.1111/j.1469-7610.2005.01520.x. View

4.
Stalker H, Keller K, Gray B, Zori R . Concurrence of fragile X syndrome and 47, XYY in an individual with a Prader-Willi-like phenotype. Am J Med Genet A. 2002; 116A(2):176-8. DOI: 10.1002/ajmg.a.10001. View

5.
Holland A, Treasure J, Coskeran P, Dallow J . Characteristics of the eating disorder in Prader-Willi syndrome: implications for treatment. J Intellect Disabil Res. 1995; 39 ( Pt 5):373-81. DOI: 10.1111/j.1365-2788.1995.tb00541.x. View